The second quarter featured 14 device merger and acqusition transactions, four of which had disclosed values that together totaled $2bn, versus the first quarter, when 24 deals totaled $10.2bn.
The top device M&A deal of the second quarter was Tecan Group AG’s definitive agreement to acquire Paramit (a privately held OEM developer and manufacturer of medical devices and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?